CSF3 and Cirrhosis: Several studies have shown that G-CSF therapy decreases the occurrence of infections in patients with cirrhosis, indicating immunomodulatory effects.[187], [188], [189] Interestingly, beta-blockers have recently shown potential to improve neutrophil phagocytic capacity in cirrhosis.190